CVE-2023-45185
CVE-2023-45185 is a high-severity vulnerability in Ibm I Access Client Solutions with a CVSS 3.x base score of 7.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-863.
Key facts
- Severity: High (CVSS 3.x base score 7.4)
- EPSS exploit prediction: 1% (58th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-863
- Affected product: Ibm I Access Client Solutions
- Published:
- Last modified:
Description
IBM i Access Client Solutions 1.1.2 through 1.1.4 and 1.1.4.3 through 1.1.9.3 could allow an attacker to execute remote code. Due to improper authority checks the attacker could perform operations on the PC under the user's authority. IBM X-Force ID: 268273.
Frequently asked questions
- What is CVE-2023-45185?
- IBM i Access Client Solutions 1.1.2 through 1.1.4 and 1.1.4.3 through 1.1.9.3 could allow an attacker to execute remote code. Due to improper authority checks the attacker could perform operations on the PC under the user's authority. IBM X-Force ID: 268273.
- How severe is CVE-2023-45185?
- CVE-2023-45185 has a CVSS 3.x base score of 7.4, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
- Is CVE-2023-45185 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (58th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-45185?
- CVE-2023-45185 affects Ibm I Access Client Solutions. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-45185?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2023-45185 published?
- CVE-2023-45185 was published on 2023-12-14 and last updated on 2026-06-17.
References
- https://exchange.xforce.ibmcloud.com/vulnerabilities/268273
- https://www.ibm.com/support/pages/node/7091942
Affected products (1)
- cpe:2.3:a:ibm:i_access_client_solutions:*:*:*:*:*:*:*:*
More vulnerabilities in Ibm I Access Client Solutions
- CVE-2023-45182 — High (CVSS 7.4): IBM i Access Client Solutions 1.1.2 through 1.1.4 and 1.1.4.3 through 1.1.9.3 is vulnerable to having its key for an…
- CVE-2022-40746 — High (CVSS 7.2): IBM i Access Family 1.1.2 through 1.1.4 and 1.1.4.3 through 1.1.9.0 could allow a local authenticated attacker to…
- CVE-2023-45184 — Medium (CVSS 6.2): IBM i Access Client Solutions 1.1.2 through 1.1.4 and 1.1.4.3 through 1.1.9.3 could allow an attacker to obtain a…
- CVE-2024-22318 — Medium (CVSS 5.1): IBM i Access Client Solutions (ACS) 1.1.2 through 1.1.4 and 1.1.4.3 through 1.1.9.4 is vulnerable to NT LAN Manager…
All CVEs affecting Ibm I Access Client Solutions →
Other CWE-863 (Incorrect Authorization) vulnerabilities
- CVE-2026-48286 — Critical (CVSS 10.0): Adobe Campaign Classic (ACC) versions 7.4.3 build 9396 and earlier are affected by an Incorrect Authorization…
- CVE-2026-48303 — Critical (CVSS 10.0): Adobe Campaign Classic (ACC) versions 7.4.3 build 9394 and earlier are affected by an Incorrect Authorization…
- CVE-2026-44330 — Critical (CVSS 10.0): free5GC is an open-source implementation of the 5G core network. Prior to 4.2.2, free5GC's NEF mounts the…
- CVE-2026-46595 — Critical (CVSS 10.0): Previously, CVE-2024-45337 fixed an authorization bypass for misused ssh server configurations; if any other type of…
- CVE-2026-33105 — Critical (CVSS 10.0): Improper authorization in Microsoft Azure Kubernetes Service allows an unauthorized attacker to elevate privileges over…
- CVE-2026-32213 — Critical (CVSS 10.0): Improper authorization in Azure AI Foundry allows an unauthorized attacker to elevate privileges over a network.
Browse all CWE-863 (Incorrect Authorization) vulnerabilities →